Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Five Star Equities Issues New Research Reports on CYTK, EME, HRL and SNE

CYTK, HRL, SONY, VXLLF
Five Star Equities Issues New Research Reports on CYTK, EME, HRL and SNE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Cytokinetics, Inc. (NASDAQ: CYTK) shares spiked 29.45 percent to close at $1.89 a share Tuesday. The stock traded between $1.59 and $1.89 on volume of 13.48 million shares traded.The company announced results from ATOMIC-AHF have been accepted for presentation during a Hot Line Late Breaking Trials Session at the European Society of Cardiology Congress 2013. Shares of Cytokinetics have gained approximately 181.8 percent year-to-date.

Get more information on Cytokinetics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CYTK

Emcor Group Inc. (NYSE: EME) shares increased 5.17 percent to close at $40.72 a share Tuesday. The stock traded between $39.15 and $41.13 on volume of 735,632 shares traded. The company announced that it has agreed to acquire energy services company RepconStrickland, Inc. for approximately $455 million. Shares of Emcor have gained approximately 18.0 percent year-to-date.

Get more information on Emcor Group and free access to the in-depth equity report at:
www.FiveStarEquities.com/EME

Hormel Foods Corp. (NYSE: HRL) shares declined 3.59 percent to close at $39.19 a share Tuesday. The stock traded between $38.51 and $39.41 on volume of 2.84 million shares traded. The company has lowered its full year guidance range for fiscal 2013 to $1.88 - $1.96 per share, compared to its previous guidance of $1.93 to $2.03 per share. Shares of Hormel Foods have gained approximately 25.0 percent year-to-date.

Get more information on Hormel Foods and free access to the in-depth equity report at:
www.FiveStarEquities.com/HRL

Sony Corporation (NYSE: SNE) shares jumped3.28 percent to close at $21.40 a share Tuesday. The stock traded between $21.28 and $21.60 on volume of 4.6 million shares traded. It has been reported that Dan Loeb’s Third Point hedge fund has raised its stake in the company to 70 million shares, approximately 7 percent, from 64 million. Shares of Sony have gained approximately 91.4 percent year-to-date.

Get more information on Sony and free access to the in-depth equity report at:
www.FiveStarEquities.com/SNE

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com